VK

Venkata Kameswar Rao Edarapu

Active Director Director DIN 03096093
DIN 03096093 First appointment Jul 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Kameswar Rao Edarapu

Data last updated:

Venkata Kameswar Rao Edarapu is a Director at Starchem Bio-Tech Private Limited (since 2010). The company operates in Pharma.

DIN 03096093
Primary Designation Director
Industry Pharma
First Appointment 07 Jul 2010
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Starchem Bio-Tech Private Limited U24100AP2010PTC069374
Director07 Jul 20102010Active

Board colleagues of Venkata Kameswar Rao Edarapu

NameDINCompanyDesignation
Vijayalaxmi Venkata Edarapu03104982Starchem Bio-Tech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Starchem Bio-Tech Private Limited
Premium access

Shareholding and investment profile for Venkata Kameswar Rao Edarapu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Kameswar Rao Edarapu

Venkata Kameswar Rao Edarapu currently holds 1 directorship: Starchem Bio-Tech Private Limited (Director, since 07 Jul 2010).

Venkata Kameswar Rao Edarapu was first appointed on 07 Jul 2010 as Director at Starchem Bio-Tech Private Limited.

The current boards of Venkata Kameswar Rao Edarapu's companies include Vijayalaxmi Venkata Edarapu (Starchem Bio-Tech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available